The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox
Submit
Cancel

0
You have items in your inquiry list.
Inquire now?

18 March 2021 [Press release]

GenoScreen SARS-CoV-2 RT-qPCR Assay is now CE-IVD marked

DiagCor Life Science is proud to join the global fight against COVID-19, with our CE-IVD marked GenoScreenTM SARS-CoV-2 RT-qPCR Assay. The triplex assay design targets two viral genes and an internal control, providing simplicity and reliability for laboratory qPCR testing. The test is being used by leading local service providers to perform routine testing in Hong Kong, for large corporate and government contracts, as well as individuals.

The assay also delivered a 100% outcome in the HKSAR Department of Health’s SARS-CoV-2 Quality Assurance Program.

If you would like to learn more about our implementing our assay in your laboratory, getting tests for your organization or just for yourself, please get in touch.

Find out more here!

About DiagCor

Headquartered in Hong Kong, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, Diagcor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.



Press Contact

DiagCor Life Science

sales@diagcorlifescience.com